InvivoSciences is a pioneering brand that was established in 2001 in St. Louis, Missouri. We are dedicated to advancing pharmaceutical testing and cardiac physiology analysis through our cutting-edge technology.

Our journey began with the exclusive technology licensed from Washington University in St. Louis, which set the foundation for our innovative solutions. In 2005, InvivoSciences relocated to Wisconsin under the leadership of our esteemed founders, Dr.

Tetsuro Wakatsuki, Ayla Annac, and Dr. Elliot Elson. Since then, we have continuously evolved and collaborated with strategic partners and investors to further enhance our capabilities.

Our flagship product, iVSurfer™, is a revolutionary tool for analyzing cardiac waveforms, providing invaluable insights for drug discovery and the treatment of rare diseases. With a strong focus on research and development, InvivoSciences is at the forefront of developing a robust pipeline of solutions that have the potential to transform the pharmaceutical industry. Join us in our commitment to revolutionize healthcare.

Explore our website to learn more about our team, strategic partnerships, publications, and career opportunities. Together, let's shape the future of pharmaceutical testing and cardiac physiology analysis